Ablative Radiotherapy for Metastatic Cancer
Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Duke University · Other
This trial is looking for adults who have been diagnosed with metastatic cancer and are receiving or will receive ablative radiotherapy. Participants will be monitored for any side effects from the treatment.
You may be able to join if
- I am at least 18 years old.
- I have evidence of metastatic disease.
- I plan to receive or am currently receiving ablative radiotherapy.
- I have signed the study-specific informed consent.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe purpose of this study is to provide a registry of participants in order to assess the acute adverse event rates following ablative radiotherapy for metastatic disease.
Loading trial locations…